✦ LIBER ✦

PCN14 THE COST AND COST EFFECTIVENESS OF DASATINIB (SPRYCEL) 100 MG THERAPY FOR THE MANAGEMENT OF IMATINIB RESISTANT AND INTOLERANT PATIENTS IN CHRONIC PHASE WITH CHRONIC MYELOID LEUKEMIA (CML) IN MÉXICO

✍ Scribed by Juarez-Garcia, A; Uc-Coyoc, R; Hernandez-Rivera, G; Rangel, S; Taylor, MJ; Litalien, G; Donato, B

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PSY17 THE COST AND COST EFFECTIVENESS OF

✍ A Juarez-Garcia; L Zapata; G Vega; J Idrovo; R Rivas; JL Kramis; G Litalien; S R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PCN13 Cost-Effectiveness Analysis of Nil

✍ Niu, X.; Hay, J. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PCN69 COST-EFFECTIVENESS ANALYSIS OF DAS

✍ de Ramirez; A Arellano; U Sbarigia; MJ Taylor; P Martin; G Restovic 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PCN124 COST-UTILITY ANALYSIS OF DASATINI

✍ E Asano; M Nita; A Moellmann-Coelho; R Rached; B Donato; E Rahal 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

PSY38 A UK Based Cost-Effectiveness Anal

✍ S. Mealing; M. Taylor; D. Scott; J. Clark; M. Mckenna; M. Lebmeier; I. Gilloteau 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PHM12 COST-EFFECTIVENESS OF DASATINIBVS

✍ M Brosa; MJ Taylor; U Staginnus; A Meno Duran; KH Cerri; F Cervantes 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB